Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Filings indexed 1,969 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)
Regulatory Filings
2026-05-04 English
8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)
Regulatory Filings
2026-04-30 English
ARS - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)
Annual Report
2026-03-27 English
DEFA14A - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)
Regulatory Filings
2026-03-27 English
DEF 14A - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)
Proxy Solicitation & Information Statement
2026-03-27 English
SCHEDULE 13G - Indivior Pharmaceuticals, Inc. (0001625297) (Subject)
Major Shareholding Notification
2026-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.